In 1989, the International Agency for Research on Cancer (IARC) made a landmark decision that changed how the world views the painting profession. After reviewing epidemiological evidence from multiple countries, IARC classified occupational exposure as a painter as Group 1 — carcinogenic to humans. This classification was reaffirmed and expanded in 2010 based on additional evidence for mesothelioma and bladder cancer.

IARC's Group 1 classification is reserved for agents with sufficient evidence of carcinogenicity in humans. It sits alongside tobacco smoke, asbestos, and arsenic. The classification does not estimate risk magnitude — it establishes causation. When IARC says painting causes cancer, it means the evidence meets the highest scientific standard for causal inference.

Painting Is a Group 1 Carcinogen: What IARC's Classification Means for Workers

What Group 1 Means

Cancers with Sufficient Evidence

IARC has determined that occupational painting causes three specific cancers with sufficient evidence:

Lung Cancer

The most extensively studied outcome. The landmark Guha et al. meta-analysis (2010) synthesized 47 independent studies covering more than 11,000 incident lung cancer cases among painters. The summary relative risk was 1.35 (95% CI: 1.29–1.41), meaning painters face a 35% increased risk of lung cancer compared to the general population. Even after controlling for smoking, the risk remained 1.35 (95% CI: 1.21–1.51).

Critically, among never-smokers, the relative risk was 2.00 (95% CI: 1.09–3.67). This finding definitively excludes smoking as the sole explanation.

Bladder Cancer

A separate meta-analysis by Guha et al. (2010) of 41 studies and over 2,900 bladder cancer cases found a summary relative risk of 1.25 (95% CI: 1.16–1.34). The risk increased with duration: painters exposed for more than 10 years had a relative risk of 1.81 (95% CI: 1.20–2.75).

Mesothelioma

Painters have elevated rates of mesothelioma, primarily due to occupational asbestos exposure during building renovation and historical use of asbestos-containing paints. Scandinavian record linkage studies found a standardized incidence ratio of 1.70 (95% CI: 1.25–2.26) for pleural cancer among painters.

The SYNERGY Confirmation (2021)

The largest pooled analysis to date — SYNERGY, combining 16 case-control studies with 19,369 lung cancer cases — confirmed these findings with modern, harmonized exposure assessment. Ever-painters showed an odds ratio of 1.30 (95% CI: 1.13–1.50), with the highest risks for construction and repair painters.

Among never-smokers in SYNERGY, the risk was doubled (OR 2.04; 95% CI: 1.18–3.53), and was highest for adenocarcinoma (OR 2.63; 95% CI: 1.33–5.18).

The Smoking-Painter Interaction

SYNERGY also revealed a disturbing synergistic effect. Smoking and painting exposure interact on the additive scale (RERI 3.93; 95% CI: 1.55–6.30). Approximately 24% of lung cancers among smoker-painters are attributable to the interaction itself — meaning the combined risk exceeds what either factor produces alone.

Why Powder Coating Matters

IARC's classification applies to liquid paint application. The exposure routes — inhalation of VOCs including benzene, inhalation of pigment dust, skin contact with aromatic amines — are inherent to liquid coating systems. Powder coatings contain no VOC solvents and generate less airborne particulate during application, eliminating the primary exposure pathways that drive these cancer risks.

For government agencies and contractors, this classification is not merely academic. It represents a preventable occupational cancer risk that specification choices can eliminate entirely.